Pan C - Search Results

1

Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.

Lin W, Zhao Z, Du W, Ni Z, Pan C, Fang P, Li J, ZhuGe L, Jin S. Lin W, et al. Among authors: pan c. Dig Dis Sci. 2024 Feb;69(2):491-501. doi: 10.1007/s10620-023-08175-x. Epub 2024 Jan 3. Dig Dis Sci. 2024. PMID: 38170337

2

Protective effect of forsythiaside A on lipopolysaccharide/d-galactosamine-induced liver injury.

Pan CW, Zhou GY, Chen WL, Zhuge L, Jin LX, Zheng Y, Lin W, Pan ZZ. Pan CW, et al. Int Immunopharmacol. 2015 May;26(1):80-5. doi: 10.1016/j.intimp.2015.03.009. Epub 2015 Mar 20. Int Immunopharmacol. 2015. PMID: 25797347

3

Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy.

Hu J, Xu C, Cheng B, Jin L, Li J, Gong Y, Lin W, Pan Z, Pan C. Hu J, et al. Among authors: pan c, pan z. Tumour Biol. 2016 Jan;37(1):331-9. doi: 10.1007/s13277-015-3591-z. Epub 2015 Jul 29. Tumour Biol. 2016. PMID: 26219890

4

Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.

Pan CW, Pan ZZ, Hu JJ, Chen WL, Zhou GY, Lin W, Jin LX, Xu CL. Pan CW, et al. Eur J Pharmacol. 2016 Jan 5;770:85-91. doi: 10.1016/j.ejphar.2015.12.006. Epub 2015 Dec 5. Eur J Pharmacol. 2016. PMID: 26668000

5

Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.

Pan C, Chen Y, Chen W, Zhou G, Jin L, Zheng Y, Lin W, Pan Z. Pan C, et al. Among authors: pan z. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:255-259. doi: 10.1016/j.jchromb.2015.11.056. Epub 2015 Dec 3. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 26684720

6

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.

Pan C, Wang X, Shi K, Zheng Y, Li J, Chen Y, Jin L, Pan Z. Pan C, et al. Among authors: pan z. PLoS One. 2016 May 3;11(5):e0152090. doi: 10.1371/journal.pone.0152090. eCollection 2016. PLoS One. 2016. PMID: 27138141 Free PMC article.

7

The protective effect of juglanin on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats.

Zhou GY, Yi YX, Jin LX, Lin W, Fang PP, Lin XZ, Zheng Y, Pan CW. Zhou GY, et al. Biomed Pharmacother. 2016 Jul;81:318-328. doi: 10.1016/j.biopha.2016.04.013. Epub 2016 Apr 23. Biomed Pharmacother. 2016. PMID: 27261609

8

MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4.

Xu C, Shi L, Chen W, Fang P, Li J, Jin L, Pan Z, Pan C. Xu C, et al. Among authors: pan c, pan z. Oncotarget. 2017 Jun 27;8(26):41921-41931. doi: 10.18632/oncotarget.16707. Oncotarget. 2017. PMID: 28410209 Free PMC article.

9

HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells.

Zheng Y, Li J, Pan C, Zhou G, Zhuge L, Jin L, Fang P. Zheng Y, et al. Among authors: pan c. DNA Cell Biol. 2017 Jun;36(6):490-500. doi: 10.1089/dna.2016.3626. Epub 2017 Apr 21. DNA Cell Biol. 2017. PMID: 28430527

10

Shikonin protects against D-Galactosamine and lipopolysaccharide-induced acute hepatic injury by inhibiting TLR4 signaling pathway.

Lin MX, Yi YX, Fang PP, Huang SS, Pan CW, Jin LX, Zhang T, Zhou GY. Lin MX, et al. Oncotarget. 2017 Sep 16;8(53):91542-91550. doi: 10.18632/oncotarget.21070. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,332 results

Search Page

Filters